LIGHT sensitizes IFNγ-mediated apoptosis of HT-29 human carcinoma cells through both death receptor and mitochondria pathways

Cell Research

Volumn 14, Issue 2, 2004, Pages 117-124

  Zhang, Man Chao ^a,b   Liu, Hong Peng ^a   Demchik, Lisa L ^a   Zhai, Yi Fan ^a   Yang, Da Jun ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b 3111 CCGC ^*  (United States)

Author keywords

Apoptosis; Bcl XL; Caspase; HT 29; LIGHT

Indexed keywords

HERPESVIRIDAE; SIMPLEXVIRUS;

BAK1 PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; BENZOYLCARBONYL ASPARTYL GLUTAMYL VALYL ASPARTYL FLUOROMETHYL KETONE; BENZOYLCARBONYL-ASPARTYL-GLUTAMYL-VALYL-ASPARTYL-FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE; CYSTEINE PROTEINASE INHIBITOR; GAMMA INTERFERON; HERPESVIRUS ENTRY MEDIATOR LIGAND; MEMBRANE PROTEIN; OLIGOPEPTIDE; PEPTIDE CHLOROMETHYL KETONE; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL X; TNFSF14 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL STRAIN HT29; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; METABOLISM; MITOCHONDRION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-X PROTEIN; CASPASES; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; HT29 CELLS; HUMANS; INTERFERON TYPE II; MEMBRANE PROTEINS; MITOCHONDRIA; OLIGOPEPTIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14; TUMOR NECROSIS FACTOR-ALPHA;

EID: 16544380951     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7290210     Document Type: Article

References (57)

1. Mauri DN, Ebner R, Montgomery RI, et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998; 8:21-30
2. Harrop JA, McDonnell PC, Brigham-Burke M, et al. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 1998; 273:27548-56.
3. Rooney IA, Butrovich KD, Glass AA, et al. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT- mediated apoptosis of tumor cells. J Biol Chem 2000; 275:14307-15.
4. Yang D, Zhai Y, Zhang M. LIGHT, a new member of the TNF superfamily. J Biol Regul Homeost Agents 2002; 16:206-10.
5. Zhai Y, Guo R, Hsu TL, et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 1998; 102:1142-51.
6. Hikichi Y, Matsui H, Tsuji I, et al. LIGHT, a member of the TNF superfamily, induces morphological changes and delays proliferation in the human rhabdomyosarcoma cell line RD. Biochem Biophys Res Commun 2001; 289:670-7.
7. Matsui H, Hikichi Y, Tsuji I, Yamada T, Shintani Y. LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis. J Biol Chem, 2002; 277:50054-61.
8. Tamada K, Shimozaki K, Chapoval AI, et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 2000; 164 :4105-10.
9. Tamada K, Shimozaki K, Chapoval AI, et al. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med 2000; 6:283-9.
10. Wang J, Lo JC, Foster A, et al. The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest 2001; 108: 1771-80.
11. Shaikh RB, Santee S, Granger SW, et al. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 2001; 167:6330-7.
12. Liu J, Schmidt CS, Zhao F, et al. LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function. Int Immunol 2003; 15:861-70.
13. Lama J, Ware CF. Human immunodeficiency virus type 1 Nef mediates sustained membrane expression of tumor necrosis factor and the related cytokine LIGHT on activated T cells. J Virol 2000; 74:9396-402.
14. Fava RA, Notidis E, Hunt J, et al. A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J Immunol 2003; 171:115-26,
15. Sarrias MR, Whitbeck JC, Rooney I, et al. The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA. Mol Immunol 2000; 37:665-73.
16. Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999; 274:13733-6.
17. Chen MC, Hsu TL, Luh TY, et al. Overexpression of bcl-2 enhances LIGHT- and interferon-gamma-mediated apoptosis in Hep3BT2 cells. J Biol Chem 2000; 275:38794-801.
18. Zhang M, Guo R, Zhai Y, et al. Light stimulates IFNγ-Mediated intercellular adhesion molecule-1 upregulation of cancer cells. Hum Immunol 2003; 64:416-26.
19. Zhang M, Guo R, Zhai Y, et al. LIGHT sensitizes IFNγ-Mediated apoptosis of MDA-MB-231 breast cancer cells leading to down-regulation of anti-apoptosis Bcl-2 family members. Cancer Letters 2003; 201-10.
20. Amundson SA, Myers TG, Scudiero D, et al. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res 2000; 60:6101-10.
21. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol 2003; 22:15-20.
22. Schultz DR, Harrington W, J Jr. Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 2003; 32:345-69.
23. Thorburn A. Death receptor-induced cell killing. Cell Signal 2004; 16:139-44.
24. Sabol SL, Li R, Lee TY, Abdul-Khalek R. Inhibition of apoptosis associated DNA fragmentation activity in nonapoptotic cells: the role of DNA fragmentation factor-45 (DFF45/ICAD). Biochem Biophys Res Commun 253:151-8.
25. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, et al. Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication. Mol Cell Biochem 1999; 193:137-48.
26. Finnegan NM, Curtin JF, Prevost G, et al. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions. Br J Cancer 2001; 85:115-21.
27. Pal'tsev MA, Demura SA, Kogan EA, et al. Role of Bcl-2, Bax, and Bak in spontaneous apoptosis and proliferation in neuroendocrine lung tumors: immunohistochemical study. Bull Exp Biol Med 2000; 130:697-700.
28. Pataer A, Smythe WR, Yu R, et al. Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines. J Thorac Cardiovasc 2001; Surg 121:61-67.
29. Wang GQ, Gastman BR, Wieckowski E, et al. A Role for Mitochondrial Bak in Apoptotic Response to Anticancer Drugs. J Biol Chem 2001; 276:34307-17.
30. Li X, Marani M, Mannucci R, et al. Overexpression of BCL-X (L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res 2001; 61:1699-706.
31. Eggert A, Grotzer MA, Zuzak TJ, et al. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 2001; 61:1314-9.
32. Fulda S, Meyer E, Friesen C, et al. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 2001; 20:1063-75.
33. Siegmund D, Mauri D, Peters N, et al. FADD and Caspase-8 mediate up-regulation of c-fos by FasL and TRAIL via a FLIP-regulated pathway. J Biol Chem 2001;276:32585-90.
34. Schulze-Osthoff K, Ferrari D, Los M, et al. Apoptosis signaling by death receptors. Eur J Biochem 1998; 254:439-59.
35. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281:1309-12.
36. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 10:369-77.
37. Chauhan D, Rosen S, Reed JC, et al. APAF-1/cytochrome-C independent and SMAC-dependent induction of apotosis in multiple myeloma (MM) cells. J Biol Chem 2001; 276:24453-6.
38. Srinivasula SM, Datta P, Fan XJ, et al. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 2000; 275:36152-7.
39. Du C, Fang M, Li Y, Li L, et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102:33-42.
40. Bratton SB, Walker G, Srinivasula SM, et al. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J 2001; 20:998-1009.
41. Purring-Koch C, McLendon G. Cytochrome c binding to Apaf-1: the effects of dATP and ionic strength. Proc Natl Acad Sci USA 2000; 97:11928-31.
42. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 2000; 275:31199-203.
43. Granville DJ, Cassidy B A, Ruehlmann, DO et al. Mitochondrial release of apoptosis-inducing factor and cytochrome c during smooth muscle cell apoptosis. Am J Pathol 2001; 159:305-11.
44. Joza N, Susin SA, Daugas E, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410:549-54.
45. Loeffler M, Daugas E, Susin SA, et al. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J 2001; 15:758-67.
46. Rath PC, Aggarwal BB. TNF-induced signaling in apoptosis. J Clin Immunol 1999; 19:350-64.
47. Wallach D, Varfolomeev EE, Malinin NL, et al. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999; 17:331-67.
48. Smyth MJ, Johnstone RW. Role of TNF in lymphocyte-mediated cytotoxicity. Microsc.Res.Tech 2000; 50:196-208.
49. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11:372-7.
50. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104:487-501.
51. Denecker G, Vercammen D, Declercq W, et al. Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci 58:356-70.
52. Kolenko VM, Uzzo RG, Bukowski R, et al. Caspase-dependent and -independent death pathways in cancer therapy. Apoptosis 2000; 5:17-20.
53. Miyazaki K, Yoshida H, Sasaki M, et al. Caspase-independent cell death and mitochondrial disruptions observed in the apaf1-deficient cells. J Biochem.(Tokyo) 2001; 129:963-9.
54. Asao H, Fu XY. Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation. J Biol Chem 2000; 275:867-74.
55. L. Eur J Immunol 1998; 28:4398-408.
56. Spets H, Georgii-Hemming P, Siljason J, et al. Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines. Blood 1998; 92:2914-23.
57. Chin YE, Kitagawa M, Kuida K, et al. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997; 17:5328-37.